Skip to main content

The Chemours Company

corporate_fare Company Profile

The Chemours Company

CC·NYSE·Basic Materials·CIK 0001627223

The Chemours Company is a leading, global provider of performance chemicals that are essential inputs in various end-products and industrial processes. The company offers customized solutions through a wide range of industrial and specialty chemical products for markets such as refrigeration and air conditioning, paints and coatings, plastics, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Its principal products include refrigerants, titanium dioxide (TiO2) pigment, and industrial fluoropolymer resins. Chemours manages its operations through three reportable segments. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. The Titanium Technologies segment supplies TiO2 pigment, a premium white pigment used for whiteness, brightness, opacity, and protection in various applications. The Advanced Performance Materials segment offers high-end polymers and advanced materials with attributes like low friction coefficients, extreme temperature resistance, weather resistance, ultraviolet and chemical resistance, and electrical insulation. The company operates 28 major production facilities across eight countries and serves approximately 2,400 customers in about 110 countries. As of December 31, 2025, no single customer accounted for more than 10% of consolidated net sales, and one customer represented approximately 7% of total outstanding accounts and notes receivables balance.

The Chemours Company (NYSE:CC) is a publicly traded company in the Basic Materials sector. Wiseek monitors CC SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Chemours Reports Q1 Adj. EPS $0.05, $1.39B Revenue; Guides Q2 Sales Up 15-20%
  • Chemours Q1 Loss Deepens to $(0.19) EPS as Revenue Sees Modest Gain
  • Chemours Reports Increased Q1 Net Loss, Reduces Debt by €140M from Asset Sale
  • Shareholders Approve New Equity Incentive Plan Authorizing Over 6 Million Shares
  • Chemours Closes $700M Senior Notes Offering at 7.875% to Refinance Existing Debt

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$5.81B
Net Income
-$386M
Diluted EPS
-$2.57
Op. Cash Flow
$264M
Free Cash Flow
$51M
Gross Profit
$902M
Cash & Equivalents
$670M
Total Debt
$4.14B
Debt / Equity
16.56×
Net Margin
-6.6%
Shares Outstanding
149.89M sh
Source: 10-K · filed 2026-02-24 · accession 0001193125-26-065201
Browse all tickers starting with C →
$22.24 +0.24% today
52-week range · as of 2026-05-05 $9.13 – $28.67
Market cap
$3.31B
Volume
1.2M (0.4× avg)
3-mo avg 2.8M
Live data · 2026-06-14 05:13 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CC - Latest Insights

CC
May 06, 2026, 4:07 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $23.67
Real-time Price: $22.24 info
Change: -$1.43 (-6%) info
Market Cap: $3.308B info
CC
May 05, 2026, 5:11 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $27.18
Real-time Price: $22.24 info
Change: -$4.94 (-18%) info
Market Cap: $3.308B info
CC
May 05, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $27.11
Real-time Price: $22.24 info
Change: -$4.87 (-18%) info
Market Cap: $3.308B info
CC
Apr 29, 2026, 9:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.01
Real-time Price: $22.24 info
Change: -$3.77 (-14%) info
Market Cap: $3.308B info
CC
Mar 12, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.70
Real-time Price: $22.24 info
Change: +$4.54 (+26%) info
Market Cap: $3.308B info
CC
Feb 26, 2026, 4:56 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.50
Real-time Price: $22.24 info
Change: +$4.74 (+27%) info
Market Cap: $3.308B info
CC
Feb 24, 2026, 7:14 AM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $18.04
Real-time Price: $22.24 info
Change: +$4.20 (+23%) info
Market Cap: $3.308B info
CC
Feb 19, 2026, 4:40 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.97
Real-time Price: $22.24 info
Change: +$2.27 (+11%) info
Market Cap: $3.308B info
CC
Jan 16, 2026, 6:49 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $14.87
Real-time Price: $22.24 info
Change: +$7.37 (+50%) info
Market Cap: $3.308B info